BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7678574)

  • 21. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
    Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
    Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
    Wang YL; Li G; Wu D; Liu YW; Yao Z
    Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
    Wang X; Zhou Y; Ying X; Guo L; Zhao Y; Fang Y
    Clin Chim Acta; 2007 Apr; 379(1-2):158-62. PubMed ID: 17250819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
    Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
    Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
    Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
    Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
    Sun HC; Tang ZY; Zhou G; Li XM
    J Exp Clin Cancer Res; 1998 Sep; 17(3):307-11. PubMed ID: 9894767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
    Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
    Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
    Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
    Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
    Peng SY; Ou YH; Chen WJ; Li HY; Liu SH; Pan HW; Lai PL; Jeng YM; Chen DC; Hsu HC
    Int J Oncol; 2005 Apr; 26(4):1053-61. PubMed ID: 15754002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small hepatocellular carcinoma with minute satellite nodules.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Honda H; Sugimachi K
    Hepatogastroenterology; 2000; 47(34):1063-6. PubMed ID: 11020880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
    Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
    J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [AFP gene expression and antigenic protein localization in the cells of hepatocellular carcinoma and its surrounding tissues].
    Dai YM
    Zhonghua Yi Xue Za Zhi; 1989 Nov; 69(11):625-8, 44. PubMed ID: 2483982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma.
    Pirisi M; Fabris C; Luisi S; Santuz M; Toniutto P; Vitulli D; Federico E; Del Forno M; Mattiuzzo M; Branca B; Petraglia F
    Cancer Detect Prev; 2000; 24(2):150-5. PubMed ID: 10917135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.